National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Global Research
 US-Japan Program
 Africa
 East Asia and Pacific
 Near East
 South and Central Asia
  Bangladesh
  India


Global Research

South and Central Asia

The South and Central Asian region comprises the countries of Afghanistan, Bangladesh, Bhutan, India, Kazakhstan, Kyrgyzstan, Maldives, Nepal, Pakistan, Sri Lanka, Tajikistan, Turkmenistan, and Uzbekistan.

Thumbnail map of South and Central Asia
View a full-size interactive Google map of Asia
The region has experienced social, economic, and technological transformations, yet it faces unpredictable problems in the areas of health, natural disasters, and conflict: HIV/AIDS, tuberculosis (TB), and malaria are challenges; natural disasters such as tsunamis and earthquakes strain the region’s limited resources and lead to increased health and survival risks; isolated but ongoing conflicts jeopardize peace, stability, and development in the region.

In India, NIAID’s priorities for research include HIV/AIDS, with additional funding for research on HIV co-infections, TB, filariasis, leishmania, and other diseases. NIAID funds major research projects in Bangladesh that are focused on endemic diseases, such as cholera, amebiasis, and cryptosporidiosis; and on enteric pathogens, such as Vibrio cholerae and Entamoeba histolytica. NIAID also funds leprosy research in Nepal.

The U.S. government has science and technology agreements with both India and Bangladesh that facilitate research and collaboration.

Countries With NIAID-Funded Activities

Additional countries where NIAID is conducting and supporting research will be added. This information is not meant to be a complete list of NIAID research and NIAID-sponsored activities.

Related Links

Government

Non-government

back to top

IndiaBangladeshThailandIndonesia

Research Feature

Photo of Monsoon flooding of the Jamuna River.

Hepatitis E Vaccine: A Time of Testing

Facing numerous and dauntless hurdles, a field research team tested the efficacy of the hepatitis E vaccine in Nepal. Read about the challenges and successes of the hepatitis E vaccine trial.


See Also

HIV/AIDS

Tuberculosis (TB)

Malaria

Influenza

Hepatitis

The Story of the Hepatitis E Vaccine

Center of Excellence for Influenza Research and Surveillance

Indo-U.S. Vaccine Action Program 

Director Commentaries

25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (Commentary by NIAID Director Anthony S. Fauci published in Cell)—Nov. 2, 2007



Research Feature

Photo of Monsoon flooding of the Jamuna River.

Hepatitis E Vaccine: A Time of Testing

Facing numerous and dauntless hurdles, a field research team tested the efficacy of the hepatitis E vaccine in Nepal. Read about the challenges and successes of the hepatitis E vaccine trial.


See Also

HIV/AIDS

Tuberculosis (TB)

Malaria

Influenza

Hepatitis

The Story of the Hepatitis E Vaccine

Center of Excellence for Influenza Research and Surveillance

Indo-U.S. Vaccine Action Program 

Director Commentaries

25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (Commentary by NIAID Director Anthony S. Fauci published in Cell)—Nov. 2, 2007